Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.

BMC cancer

Volumn 12, Issue , 2012, Pages

  Thaler, Josef ^a   Karthaus, Meinolf ^b   Mineur, Laurent ^b   Greil, Richard ^b   Letocha, Henry ^b   Hofheinz, Ralf ^b   Fernebro, Eva ^b   Gamelin, Erick ^b   Baños, Ana ^b   Köhne, Claus Henning ^b  

^a Hospital Wels Grieskirchen   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; FLUOROURACIL; FOLINIC ACID; MONOCLONAL ANTIBODY; PANITUMUMAB;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COLORECTAL TUMOR; DRUG EFFECT; FEMALE; FOLLOW UP; GENETICS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MUTATION; ONCOGENE RAS; PATHOLOGY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; SKIN; SKIN DISEASE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GENES, RAS; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MUTATION; QUALITY OF LIFE; SKIN; SKIN DISEASES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84866646369     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-438     Document Type: Article

References (0)